Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001389723 | SCV001591175 | pathogenic | not provided | 2022-07-06 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EYS-related conditions. ClinVar contains an entry for this variant (Variation ID: 1075992). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Thr2271Argfs*11) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). |
DBGen Ocular Genomics | RCV001587393 | SCV001816102 | pathogenic | Retinitis pigmentosa 25 | 2021-06-07 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV001724309 | SCV001950273 | likely pathogenic | Retinitis pigmentosa | 2021-04-01 | criteria provided, single submitter | curation | The p.Thr2271ArgfsTer11 variant in EYS was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab (https://oculargenomics.meei.harvard.edu/labs/pierce-lab/lab-members/). Through a review of available evidence we were able to apply the following criteria: PVS1, PM2. Based on this evidence we have classified this variant as Likely Pathogenic. If you have any questions about the classification please reach out to the Pierce Lab. |
Baylor Genetics | RCV001587393 | SCV004195214 | likely pathogenic | Retinitis pigmentosa 25 | 2023-08-12 | criteria provided, single submitter | clinical testing |